Innoviva Valuation
| INVA Stock | USD 18.99 0.06 0.31% |
At this time, the firm appears to be overvalued. Innoviva retains a regular Real Value of $16.65 per share. The prevalent price of the firm is $18.99. Our model calculates the value of Innoviva from evaluating the firm fundamentals such as Return On Equity of 0.0997, return on asset of 0.0937, and Current Valuation of 1.38 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Innoviva's valuation include:
Price Book 1.7782 | Enterprise Value 1.4 B | Enterprise Value Ebitda 11.1931 | Price Sales 3.3808 | Trailing PE 23.7375 |
Overvalued
Today
Please note that Innoviva's price fluctuation is very steady at this time. Calculation of the real value of Innoviva is based on 3 months time horizon. Increasing Innoviva's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Innoviva is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Innoviva Stock. However, Innoviva's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.99 | Real 16.65 | Target 14.0 | Hype 18.99 | Naive 19.11 |
The real value of Innoviva Stock, also known as its intrinsic value, is the underlying worth of Innoviva Company, which is reflected in its stock price. It is based on Innoviva's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Innoviva's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Innoviva helps investors to forecast how Innoviva stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innoviva more accurately as focusing exclusively on Innoviva's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Innoviva's intrinsic value based on its ongoing forecasts of Innoviva's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Innoviva's closest peers. If more than one evaluation category is relevant for Innoviva we suggest using both methods to arrive at a better estimate.
Innoviva Cash |
|
Innoviva Valuation Trend
Comparing Innoviva's enterprise value against its market capitalization is a good way to estimate the value of Innoviva uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Innoviva Revenue by Product
Innoviva Total Value Analysis
Innoviva is currently anticipated to have valuation of 1.38 B with market capitalization of 1.19 B, debt of 449.08 M, and cash on hands of 283.58 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Innoviva fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.38 B | 1.19 B | 449.08 M | 283.58 M |
Innoviva Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innoviva has Price/Earnings To Growth (PEG) ratio of 0.24. The entity last dividend was issued on the 8th of September 2015. The firm had 1241:1000 split on the 3rd of June 2014. Based on the key measurements obtained from Innoviva's financial statements, Innoviva is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in January.Innoviva Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Innoviva has an asset utilization ratio of 24.97 percent. This suggests that the Company is making $0.25 for each dollar of assets. An increasing asset utilization means that Innoviva is more efficient with each dollar of assets it utilizes for everyday operations.Innoviva Ownership Allocation
The majority of Innoviva outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innoviva to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innoviva. Please pay attention to any change in the institutional holdings of Innoviva as this could imply that something significant has changed or is about to change at the company.Innoviva Profitability Analysis
The company reported the previous year's revenue of 310.46 M. Net Income was 179.72 M with profit before overhead, payroll, taxes, and interest of 276.11 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Innoviva's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Innoviva and how it compares across the competition.
About Innoviva Valuation
The stock valuation mechanism determines Innoviva's current worth on a weekly basis. Our valuation model uses a comparative analysis of Innoviva. We calculate exposure to Innoviva's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Innoviva's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 261.1 M | 274.1 M | |
| Pretax Profit Margin | 0.63 | 0.66 | |
| Operating Profit Margin | 0.57 | 0.60 | |
| Net Profit Margin | 0.58 | 0.61 | |
| Gross Profit Margin | 0.84 | 0.54 |
Innoviva Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 86.9 M | |
| Quarterly Earnings Growth Y O Y | -0.98 |
Innoviva Current Valuation Indicators
Valuation refers to the process of determining the present value of Innoviva and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Innoviva we look at many different elements of the entity such as Innoviva's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Innoviva, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Innoviva's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Innoviva's worth.Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |